Human cytomegalovirus virion proteins

Human Immunology

Volumn 65, Issue 5, 2004, Pages 395-402

  Britt, William J ^a,b   Boppana, Suresh ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b Children's Harbor Building 107 ^*  (United States)

Author keywords

Human cytomegalovirus; virion structural proteins; viron proteins

Indexed keywords

GLYCOPROTEIN B; GLYCOPROTEIN H; GLYCOPROTEIN L; GLYCOPROTEIN M; GLYCOPROTEIN N; GLYCOPROTEIN O; GLYCOPROTEIN TRL 10; GLYCOPROTEIN TRL 11; GLYCOPROTEIN UL132; PROTEOME; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

HUMAN CYTOMEGALOVIRUS; MASS SPECTROMETRY; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEOMICS; SHORT SURVEY; STRUCTURE ANALYSIS; VIRION; VIRUS CAPSID; VIRUS ENVELOPE;

EID: 2542472221     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2004.02.008     Document Type: Article

References (98)

1. Chee M.S., Bankier A.T., Beck S., Bohni R., Brown C.M., Cerny R., Horsnell T., Hutchison C.A., Kouzarides T., Martignetti J.A., Preddie E., Satchwell S.C., Tomlinson P., Weston K.M., Barrell B.G. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol. 154:1990;125
2. Cha T., Tom E., Kembel G.W., Duke G.M., Mocarski E.S., Spaete R.R. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol. 70:1996;78
3. Murphy E., Yu D., Grimwood J., Schmutz J., Dickson M., Jarvis M.A., Nelson J.A., Myers R.M., Shenk T.E. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci U S A. 100:2003;14976
4. Baldick C.J. Jr, Shenk T. Proteins associated with purified human cytomegalovirus particles. J Virol. 70:1996;6097
5. Borst E.M., Hahn G., Koszinowski U.H., Messerle M. Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli a new approach for construction of HCMV mutants. J Virol. 73:1999;8320
6. Borst E.M., Mathys S., Wagner M., Muranyi W., Messerle M. Genetic evidence of an essential role for cytomegalovirus small capsid protein in viral growth. J Virol. 75:2001;1450
7. Silva M.C., Yu Q.C., Enquist L., Shenk T. Human cytomegalovirus UL99-encoded pp28 is required for the cytoplasmic envelopment of tegument-associated capsids. J Virol. 77:2003;10594
8. Britt W.J., Jarvis M.A., Seo J.Y., Drummond D., Nelson J. Rapid genetic engineering of human cytomegalovirus by using a lambda phage linear recombination system demonstration that pp28 (UL99) is essential for production of infectious virus. J Virol. 78:2004;539
9. Hahn G., Khan H., Baldanti F., Koszinowski U.H., Revello M.G., Gerna G. The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics. J Virol. 76:2002;9551
10. Mocarski E.S., Tan Courcelle C. Cytomegaloviruses and their replication. Howley D.M.K. Fields Virology. vol 2:2001;Lippincott Williams and Wilkins, Philadelphia
11. Rawlinson W.D., Farrell H.E., Barrell B.G. Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol. 70:1996;8833
12. Vink C., Beuken E., Bruggeman C.A. Complete DNA sequence of the rat cytomegalovirus genome. J Virol. 74:2000;7656
13. Davison A.J., Dolan A., Akter P., Addison C., Dargan D.J., Alcendor D.J., McGeoch D.J., Hayward G.S. The human cytomegalovirus genome revisited comparison with the chimpanzee cytomegalovirus genome. [erratum appears in J Gen Virol 2003 Apr;84(Pt 4):1053]. J Gen Virol. 84:2003;17
14. Hansen S.G., Strelow L.I., Franchi D.C., Anders D.G., Wong S.W. Complete sequence and genomic analysis of rhesus cytomegalovirus. J Virol. 77:2003;6620
15. Child S., Jarrahian S., Harper V., Geballe A. Complementation of vaccinia virus lacking the double stranded RNA-binding protein gene E3L by human cytomegalovirus. J Virol. 76:2002;4912
16. Fortunato E.A., McElroy A.K., Sanchez I., Spector D.H. Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol. 8:2000;111
17. Meier J.L., Stinski M.F. Effect of a modulator deletion on transcription of the human cytomegalovirus major immediate-early genes in infected undifferentiated and differentiated cells. J Virol. 71:1997;1246
18. Kalejta R.F., Bechtel J.T., Shenk T. Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors. Molec Cell Biol. 23:2003;1885
19. Kalejta R.F., Shenk T. The human cytomegalovirus UL82 gene product (pp71) accelerates progression through the G1 phase of the cell cycle. J Virol. 77:2003;3451
20. Alcami A., Koszinowski U.H. Viral mechanisms of immune evasion. Immunol Today. 21:2000;447
21. Fish K.N., Soderberg-Naucler C., Mills L.K., Stenglein S., Nelson J.A. Human cytomegalovirus persistently infects aortic endothelial cells. J Virol. 72:1998;5661
22. Fish K.N., Britt W., Nelson J.A. A novel mechanism for persistence of human cytomegalovirus in macrophages. J Virol. 70:1996;1855
23. Taylor-Wiedeman J., Sissons P., Sinclair J. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J Virol. 68:1994;1597
24. Soderberg-Naucler C., Fish K.N., Nelson J.A. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell. 91:1997;119
25. Arav-Boger R., Willoughby R.E., Pass R.F., Zong J.C., Jang W.J., Alcendor D., Hayward G.S. Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease. J Infect Dis. 186:2002;1057
26. Chen D.H., Jiang H., Lee M., Liu F., Zhou Z.H. Three-dimensional visualization of tegument/capsid interactions in the intact human cytomegalovirus. Virology. 260:1999;10
27. Trus B.L., Gibson W., Cheng N., Steven A.C. Capsid structure of simian cytomegalovirus from cryoelectron microscopy evidence for tegument attachment sites. J Virol. 73:1999;2181
28. Gibson W. Structure and assembly of the virion. Intervirology. 39:1996;389
29. Welch A.R., Woods A.S., McNally L.M., Cotter R.J., Gibson W. A herpesvirus maturational proteinase, assemblin identification of its gene, putative active site domain, and cleavage site. Proc Natl Acad Sci U S A. 88:1991;10792
30. Gibson W., Baxter M.K., Clopper K.S. Cytomegalovirus "missing" capsid protein identified as heat-aggregable product of human cytomegalovirus UL46. J Virol. 70:1996;7454
31. Gibson W., Clopper K.S., Britt W.J., Baxter M.K. Human cytomegalovirus (HCMV) smallest capsid protein identified as product of short open reading frame located between HCMV UL48 and UL49. J Virol. 70:1996;5680
32. Newcomb W.W., Juhas R.M., Thomsen D.R., Homa F.L., Burch A.D., Weller S.K., Brown J.C. The UL6 gene product forms the portal for entry of DNA into the herpes simplex virus capsid. J Virol. 75:2001;10923
33. Heymann J.B., Cheng N., Newcomb W.W., Trus B.L., Brown J.C., Steven A.C. Dynamics of herpes simplex virus capsid maturation visualized by time-lapse cryo-electron microscopy [comment]. Nat Struct Biol. 10:2003;334
34. Newcomb W.W., Homa F.L., Thomsen D.R., Ye Z., Brown J.C. Cell-free assembly of the herpes simplex virus capsid. J Virol. 68:1994;6059
35. Newcomb W.W., Homa F.L., Thomsen D.R., Trus B.L., Cheng N., Steven A., Booy F., Brown J.C. Assembly of the herpes simplex virus procapsid from purified components and identification of small complexes containing the major capsid and scaffolding proteins. J Virol. 73:1999;4239
36. Newcomb W.W., Trus B.L., Booy F.P., Steven A.C., Wall J.S., Brown J.C. Structure of the herpes simplex virus capsid. Molecular composition of the pentons and the triplexes. J Molec Biol. 232:1993;499
37. Zhou Z.H., Dougherty M., Jakana J., He J., Rixon F.J., Chiu W. Seeing the herpesvirus capsid at 8.5 A. Science. 288:2000;877
38. McLauchlan J., Rixon F.J. Characterization of enveloped tegument structures (L particles) produced by alphaherpesviruses integrity of the tegument does not depend on the presence of capsid or envelope. J Gen Virol. 73:1992;269
39. Rixon F.J., Addison C., McLauchlan J. Assembly of enveloped tegument structures (L particles) can occur independently of virion maturation in herpes simplex type 1-infected cells. J Gen Virol. 73:1992;277
40. Sanchez V., Greis K.D., Sztul E., Britt W.J. Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication. Characterization of a potential site of virus assembly. J Virol. 74:2000;975
41. Schmolke S., Kern H.F., Drescher P., Jahn G., Plachter B. The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture. J Virol. 69:1995;5959
42. Baldick C.J. Jr, Marchini A., Patterson C.E., Shenk T. Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle. J Virol. 71:1997;4400
43. Stamminger T., Gstaiger M., Weinzierl K., Lorz K., Winkler M., Schaffner W. Open reading frame UL26 of human cytomegalovirus encodes a novel tegument protein that contains a strong transcriptional activation domain. J Virol. 76:2002;4836
44. Winkler M., Rice S.A., Stamminger T. UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression. J Virol. 68:1994;3943
45. Lu M., Shenk T. Human cytomegalovirus UL69 protein induces cells to accumulate in G1 phase of the cell cycle. J Virol. 73:1999;676
46. Gilbert M.J., Riddell S.R., Plachter B., Greenberg P.D. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature. 383:1996;720
47. Gebert S., Schmolke S., Sorg G., Floss S., Plachter B., Stamminger T. The UL84 protein of human cytomegalovirus acts as a transdominant inhibitor of immediate-early-mediated transactivation that is able to prevent viral replication. J Virol. 71:1997;7048
48. Browne E.P., Shenk T. Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proc Natl Acad Sci U S A. 100:2003;11439
49. Muranyi W., Haas J., Wagner M., Krohne G., Koszinowski U.H. Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina [comment]. Science. 297:2002;854
50. Britt W.J. Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus. Virology. 135:1984;369
51. Kari B., Liu Y.N., Goertz R., Lussenhop N., Stinski M.F., Gehrz R. Structure and composition of a family of human cytomegalovirus glycoprotein complexes designated gC-I (gB). J Gen Virol. 71:1990;2673
52. Gretch D.R., Gehrz R.C., Stinski M.F. Characterization of a human cytomegalovirus glycoprotein complex (gCI). J Gen Virol. 69:1988;1205
53. Gretch D.R., Kari B., Rasmussen L., Gehrz R.C., Stinski M.F. Identification and characterization of three distinct families of glycoprotein complexes present in the envelopes of human cytomegalovirus. J Virol. 62:1988;875
54. Mach M., Kropff B., Dal Monte P., Britt W. Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73). J Virol. 74:2000;11881
55. Hobom U., Brune W., Messerle M., Hahn G., Koszinowski U.H. Fast screening procedures for random transposon libraries of cloned herpesvirus genomes mutational analysis of human cytomegalovirus envelope glycoprotein genes. J Virol. 74:2000;7720
56. Schleiss M.R. Cloning and characterization of the guinea pig cytomegalovirus glycoprotein B gene. Virology. 202:1994;173
57. Kropff B., Mach M. Identification of the gene coding for rhesus cytomegalovirus glycoprotein B and immunological analysis of the protein. J Gen Virol. 78:1997;1999
58. Rapp M., Messerle M., Buhler B., Tannheimer M., Keil G.M., Koszinowski U.H. Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus. J Virol. 66:1992;4399
59. Billstrom M.A., Britt W.J. Postoligomerization folding of human cytomegalovirus glycoprotein B identification of folding intermediates and importance of disulfide bonding. J Virol. 69:1995;7015
60. Lopper M., Compton T. Disulfide bond configuration of human cytomegalovirus glycoprotein B. J Virol. 76:2002;6073
61. Britt W.J., Vugler L.G. Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus. J Virol. 63:1989;403
62. Gu F., Crump C.M., Thomas G. Trans-Golgi network sorting. Cell Molec Life Sci. 58:2001;1067
63. Crump C.M., Xiang Y., Thomas L., Gu F., Austin C., Tooze S.A., Thomas G. PACS-1 binding to adaptors is required for acidic cluster motif-mediated protein traffic. EMBO J. 20:2001;2191
64. Xiang Y., Molloy S.S., Thomas L., Thomas G. The PC6B cytoplasmic domain contains two acidic clusters that direct sorting to distinct trans-Golgi network/endosomal compartments. Molec Biol Cell. 11:2000;1257
65. Jarvis M.A., Fish K.N., Soderberg-Naucler C., Streblow D.N., Meyers H.L., Thomas G., Nelson J.A. Retrieval of human cytomegalovirus glycoprotein B from cell surface is not required for virus envelopment in astrocytoma cells. J Virol. 76:2002;5147
66. Tugizov S., Maidji E., Xiao J., Pereira L. An acidic cluster in the cytosolic domain of human cytomegalovirus glycoprotein B is a signal for endocytosis from the plasma membrane. J Virol. 73:1999;8677
67. Spaete R.R., Thayer R.M., Probert W.S., Masiarz F.R., Chamberlain S.H., Rasmussen L., Merigan T.C., Pachl C. Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology. 167:1988;207
68. Brucher K.H., Garten W., Klenk H.D., Shaw E., Radsak K. Inhibition of endoproteolytic cleavage of cytomegalovirus (HCMV) glycoprotein B by palmitoyl-peptidyl-chloromethyl ketone. Virology. 178:1990;617
69. Jean F., Thomas L., Molloy S.S., Liu G., Jarvis M.A., Nelson J.A., Thomas G. A protein-based therapeutic for human cytomegalovirus infection. Proc Natl Acad Sci U S A. 97:2000;2864
70. Homman-Loudiyi M., Hultenby K., Britt W., Soderberg-Naucler C. Envelopment of human cytomegalovirus occurs by budding into Golgi-derived vacuole compartments positive for gB, Rab 3, trans-golgi network 46, and mannosidase II [erratum appears in J Virol Arch 2003 Jul;77(14):8179]. J Virol. 77:2003;3191
71. Crump C.M., Hung C.H., Thomas L., Wan L., Thomas G. Role of PACS-1 in trafficking of human cytomegalovirus glycoprotein B and virus production. J Virol. 77:2003;11105
72. Jarvis M.A., Jones T.R., Drummond D., Smith P.P., Britt W.J., Nelson J.A., Baldick C.J. Jr. Phosphorylation of human cytomegalovirus glycoprotein B (gB) at the acidic cluster casein kinase 2 site (Ser900) is required for localization of gB to the trans-Golgic network and efficient virus replication. J Virol. 78:2004;285
73. Roizman B. Herpesviridae. Fields B.N., Knipe D.M., Howley P.M., Chanock R.M., Melnick J.L., Monath T.P., Roizman B., Straus S.E. Fields Virology. Third Edition:1996;Lippincott-Raven, Philadelphia
74. Li L., Nelson J.A., Britt W.J. Glycoprotein H related complexes of human cytomegalovirus identification of a third protein in the gCIII complex. J Virol. 71:1997;3090
75. Huber M.T., Compton T. The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex. J Virol. 72:1998;8191
76. Huber M.T., Compton T. Intracellular formation and processing of the heterotrimeric gH-gL-gO (gCIII) glycoprotein envelope complex of human cytomegalovirus. J Virol. 73:1999;3886
77. Mori Y., Yang X., Akkapaiboon P., Okuno T., Yamanishi K. Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46. J Virol. 77:2003;4992
78. Theiler R.N., Compton T. Distinct glycoprotein O complexes arise in a post-Golgi compartment of cytomegalovirus-infected cells. J Virol. 76:2002;2890
79. Kinzler E.R., Theiler R.N., Compton T. Expression and reconstitution of the gH/gL/gO complex of human cytomegalovirus. J Clin Virol. 25:(Suppl 2):2002;S87
80. Rasmussen L., Geissler A., Cowan C., Chase A., Winters M. The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates. J Virol. 76:2002;10841
81. Spaete R.R., Perot K., Scott P.I., Nelson J.A., Stinski M.F., Pachl C. Coexpression of truncated human cytomegalovirus gH with the UL115 gene product or the truncated human fibroblast growth factor receptor results in transport of gH to the cell surface. Virology. 193:1993;853
82. Keay S., Baldwin B. Anti-idiotype antibodies that mimic gp86 of human cytomegalovirus inhibit viral fusion but not attachment. J Virol. 65:1991;5124
83. Simpson J.A., Chow J.C., Baker J., Avdalovi N., Yuan S., Au D., Co M.S., Vasquez M., Britt W., Coelingh K.L. Neutralizing monoclonal antibodies that distinguish three antigenic sites on the human cytomegalovirus glycoprotein H have conformationally-distinct binding sites. J Virol. 67:1993;489
84. Li L., Coelingh K.L., Britt W.J. Human cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H. J Virol. 69:1995;6047
85. Mettenleiter T.C., Schreurs C., Thiel H.J., Rziha H.J. Variability of pseudorabies virus glycoprotein I expression. Virology. 158:1987;141
86. Lehner R., Meyer H., Mach M. Identification and characterization of a human cytomegalovirus gene coding for a membrane protein that is conserved among human herpesviruses. J Virol. 63:1989;3792
87. Scalzo A.A., Forbes C.A., Davis-Poynter N.J., Farrell H.E., Lyons P.A. DNA sequence and transcriptional analysis of the glycoprotein M gene of murine cytomegalovirus. J Gen Virol. 76:(Pt 11):1995;2895
88. Brack A.R., Dijkstra J.M., Granzow H., Klupp B.G., Mettenleiter T.C. Inhibition of virion maturation by simultaneous deletion of glycoproteins E, I, and M of pseudorabies virus. J Virol. 73:1999;5364
89. Tischer B.K., Schumacher D., Messerle M., Wagner M., Osterrieder N. The products of the UL10 (gM) and the UL49.5 genes of Marek's disease virus serotype 1 are essential for virus growth in cultured cells. J Gen Virol. 83:(Pt 5):2002;997
90. Dal Monte P., Pignatelli S., Mach M., Landini M.P. The product of human cytomegalovirus UL73 is a new polymorphic structural glycoprotein (gpUL73). J Human Virol. 4:2001;26
91. Pignatelli S., Dal Monte P., Rossini G., Chou S., Gojobori T., Hanada K., Guo J.J., Rawlinson W., Britt W., Mach M., Landini M.P. Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J Gen Virol. 84:(Pt 3):2003;647
92. Wei X., Decker J.M., Wang S., Hui H., Kappes J.C., Wu X., Salazar-Gonzalez J.F., Salazar M.G., Kilby J.M., Saag M.S., Komarova N.L., Nowak M.A., Hahn B.H., Kwong P.D., Shaw G.M. Antibody neutralization and escape by HIV-1. Nature. 422:2003;307
93. Spaderna S., Blessing H., Bogner E., Britt W., Mach M. Identification of glycoprotein gpTRL10 as a structural component of human cytomegalovirus. J Virol. 76:2002;1450
94. Lilley B.N., Ploegh H.L., Tirabassi R.S. Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein. J Virol. 75:2001;11218
95. Gewurz B.E., Gaudet R., Tortorella D., Wang E.W., Ploegh H.L. Virus subversion of immunity a structural perspective. Curr Opin Immunol. 13:2001;442
96. Fraile-Ramos A., Kledal T.N., Pelchen-Matthews A., Bowers K., Schwartz T.W., Marsh M. The human cytomegalovirus US28 protein is located in endocytic vesicles and undergoes constitutive endocytosis and recycling. Molec Biol Cell. 12:2001;1737
97. Margulies B.J., Browne H., Gibson W. Identification of the human cytomegalovirus G protein-coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles. Virology. 225:1996;111
98. Chang C.P., Vesole D.H., Nelson J., Oldstone M.B., Stinski M.F. Identification and expression of a human cytomegalovirus early glycoprotein. J Virol. 63:1989;3330